Manipal Global Education Ventures

Manipal Global Education Ventures is the family office and investment arm of the Manipal Group, India’s diversified education-and-medical conglomerate that operates one of the country’s largest hospital chains through Manipal Hospitals and a major academic medical system through Manipal Academy of Higher Education. Stage focus is Series A through growth with checks in the $5M to $25M range, and AI is not flagged as a primary focus. Healthcare interest centers on care delivery, tech-enabled services, and healthcare software, with the strategic logic flowing directly from Manipal Hospitals’ need for technology and service infrastructure. The right founder for Manipal is a healthcare operator with real revenue, often Series B or later, whose product can be deployed inside Manipal Hospitals or whose business creates strategic value to the Manipal Group’s broader healthcare and education footprint. Examples include hospital workflow software, clinical AI for imaging or diagnostics, revenue cycle management, patient experience platforms, and medical education technology. The wrong founder is an early seed company, a deep biotech team, or a consumer health brand without B2B traction. Intro paths run through Manipal Hospitals clinical leadership, the Manipal Academy alumni network which is one of India’s largest medical alumni networks, Bangalore institutional capital community including investment banks active in Indian healthcare such as Avendus and JM Financial, and frequent co-investors and follow-on partners including Temasek, TPG Growth, Multiples, and other major Indian PE-style investors. Direct outreach to Manipal corporate development is acknowledged but warm intros from clinical leadership or alumni materially accelerate diligence. In the pitch, lead with the specific Manipal Hospitals deployment use case and the structure of a 90 to 180 day pilot, the unit economics of a hospital deployment, and a credible plan to scale across Manipal’s network of hospitals which spans multiple cities and tier categories. Be specific about CDSCO, NMC, NPPA, and DPDPA posture, and about your data architecture given Manipal’s clinical and academic data assets. Caveats include the inherent tensions of family-office-CVC dynamics including potential exclusivity expectations, the longer diligence cycles typical of strategic investors, and the reality that Manipal’s strategic priorities can shift between fund vintages. For maturing healthcare businesses with hospital-network distribution potential, this is a powerful strategic partner.